Kovack Advisors’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$387K Buy
24,349
+13,760
+130% +$213K 0.02% 711
2026
Q1
$143K Sell
10,589
-7,868
-43% -$110K 0.01% 961
2025
Q4
$230K Buy
+18,457
New +$199K 0.01% 884
2025
Q1
Sell
-14,007
Closed -$174K 640
2024
Q4
$174K Buy
14,007
+145
+1% +$1.78K 0.02% 577
2024
Q3
$161K Sell
13,862
-638
-4% -$7.36K 0.02% 558
2024
Q2
$154K Sell
14,500
-1,765
-11% -$19.5K 0.02% 542
2024
Q1
$194K Sell
16,265
-649
-4% -$7.82K 0.02% 439
2023
Q4
$183K Sell
16,914
-2,186
-11% -$20.9K 0.02% 529
2023
Q3
$188K Buy
19,100
+425
+2% +$4.42K 0.03% 497
2023
Q2
$186K Sell
18,675
-295
-2% -$2.82K 0.02% 525
2023
Q1
$182K Buy
+18,970
New +$210K 0.02% 525
2022
Q3
Sell
-19,516
Closed -$204K 646
2022
Q2
$204K Sell
19,516
-525
-3% -$5.75K 0.03% 571
2022
Q1
$218K Buy
20,041
+475
+2% +$6.26K 0.02% 628
2021
Q4
$265K Sell
19,566
-6,789
-26% -$90.7K 0.03% 569
2021
Q3
$357K Buy
26,355
+2,237
+9% +$31.7K 0.04% 471
2021
Q2
$345K Buy
24,118
+31
+0.1% +$449 0.04% 463
2021
Q1
$336K Buy
24,087
+7,830
+48% +$128K 0.04% 415
2020
Q4
$305K Buy
+16,257
New +$265K 0.04% 401

Other funds holding VTRS

Kovack Advisors's VTRS Position: Q2 2026 in Review

Kovack Advisors increased its Viatris (VTRS) stake by 130% in Q2 2026, buying an estimated $213K and bringing the position to 24,349 shares worth $387K. The position accounts for 0.02% of the portfolio, ranked #711.

Kovack Advisors first reported a position in VTRS in Q4 2020 and has held it in 18 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Kovack Advisors held 24,349 shares of Viatris worth $387K as of Q2 2026.
  • Kovack Advisors bought 13,760 Viatris shares in Q2 2026, an estimated $213K.
  • Viatris made up 0.02% of Kovack Advisors's portfolio in Q2 2026, its #711 holding.
  • Kovack Advisors first reported a position in Viatris in Q4 2020 and has held it in 18 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.